Wedbush Issues Negative Outlook for Kura Oncology Earnings
Kura Oncology, Inc. (NASDAQ:KURA – Free Report) – Investment analysts at Wedbush dropped their Q1 2025 earnings estimates for shares of Kura Oncology in a research note issued to investors on Thursday, February 27th. Wedbush analyst R. Driscoll now anticipates that the company will post earnings per share of ($0.87) for the quarter, down from […]
Kura Oncology, Inc. (NASDAQ:KURA – Free Report) – Investment analysts at Wedbush dropped their Q1 2025 earnings estimates for shares of Kura Oncology in a research note issued to investors on Thursday, February 27th. Wedbush analyst R. Driscoll now anticipates that the company will post earnings per share of ($0.87) for the quarter, down from […]
